Two Patented Brain Magnesiums — The Builder and The Balancer — Form the Only Complete Brain Magnesium System Available

AUSTIN, Texas, July 29, 2026 /PRNewswire/ — Triquetra Health, a clinical-grade supplement company specializing in evidence-based formulation, today announced the launch of Mental Magnesium™, the first Dual-Pathway Brain Magnesium System combining two independently patented, blood-brain barrier-crossing magnesium forms: Magtein® Magnesium L-Threonate and ATA Mg® Magnesium N-Acetyl Taurinate. The cognitive wellness supplement is now available on Amazon, offering professionals, biohackers, and cognitive longevity seekers a complete brain magnesium system supported by three human randomized controlled trials and objective wearable biometric data.

Most magnesium supplements face a fundamental limitation in brain health applications: the blood-brain barrier blocks standard magnesium forms from reaching neurons in clinically meaningful concentrations. Your blood-brain barrier blocks standard magnesium — glycinate, citrate, malate, and oxide forms demonstrate adequate systemic absorption but negligible ability to raise brain tissue magnesium levels. An estimated 50% of American adults fail to meet daily magnesium recommendations, yet even consistent supplementation with standard forms may not address the brain-specific deficiency that underlies cognitive fatigue, impaired memory consolidation, and diminished mental clarity.

Mental Magnesium™ addresses this through the Dual-Pathway Brain Magnesium System: Magtein® (The Builder) crosses the blood-brain barrier to raise brain magnesium and build synaptic connections, while ATA Mg® (The Balancer) crosses through a separate lipophilic pathway and keeps neural signals smooth — not wired — through dual kainate/NMDA receptor modulation. No other product on the market combines both patented BBB-crossing forms, as doing so requires independent licensing of both Magtein® from AIDP/Magceutics and ATA Mg® from Synapharm. The formula is available at amazon.com/dp/B0G6FSM9XC.

The clinical validation supporting both primary actives is substantial. Published research in Neuron (Slutsky et al., 2010) demonstrated Magtein® is the only oral magnesium compound to significantly raise cerebrospinal fluid magnesium concentrations (p<0.001) after 24 days — Magnesium Chloride and Magnesium Gluconate produced no statistically significant CSF change in the same study. In the MMFS-01 randomized controlled trial (Liu et al., Journal of Alzheimer’s Disease, 2016), participants taking Magtein® demonstrated cognitive performance equivalent to a brain functioning 9.4 years younger, with a cognitive composite effect size of d=0.91 — one of the largest reported in any magnesium supplement RCT. ATA Mg® holds an FDA NDI No Objection Letter (NDI 1139) and has been evaluated by EFSA for safety, with a NOAEL of 2,250 mg/kg/day establishing a safety margin of 192–577× at use levels.

“Standard brain supplements have always faced the same limitation: they arrive at the bloodstream and stop,” said Sean Gill, Founder and CEO of Triquetra Health.

“Magtein® is The Builder — the only magnesium form studied to cross the blood-brain barrier and raise brain magnesium where memory and focus actually happen. ATA Mg® is The Balancer — the world’s only taurinergic magnesium that keeps neural signals smooth, not wired. The Dual-Pathway Brain Magnesium System is what complete brain magnesium supplementation finally looks like.”

Mental Magnesium™ features 1,000 mg Magtein® Magnesium L-Threonate (matching the exact dose used in the Hausenblas 2024 Oura Ring RCT), 450 mg ATA Mg® Magnesium N-Acetyl Taurinate, and a precision cofactor matrix of active Pyridoxal-5′-Phosphate (P5P, ≥99% purity), natural Vitamin D3, buffered Magnesium Ascorbate, and a Fulvic/Humic Acid Complex — representing two patented brain magnesiums, four precision cofactors, one complete system. The formula delivers 110 mg total elemental magnesium per serving (26% DV), manufactured in FDA-registered, cGMP-certified facilities with third-party testing for purity, potency, and safety.

For complete product information and clinical research summaries, visit https://triquetrahealth.com/mental-magnesium.

Mental Magnesium™ is available now on Amazon at https://www.amazon.com/dp/B0G6FSM9XC with a 60-day satisfaction guarantee. The Dual-Pathway Brain Magnesium System supports sharper days and deeper nights for professionals, biohackers, and adults building a cognitive longevity foundation.

About Triquetra Health

Triquetra Health develops research-backed supplements for cognitive wellness and neurological support. The company focuses on formulation science that maximizes bioavailability and tissue-specific delivery for meaningful clinical outcomes. Products are manufactured in FDA-registered, cGMP-certified facilities with comprehensive third-party verification. For more information, visit triquetrahealth.com.

Media Contact:
LeAnna Doughty – Director of Communications
leanna@triquetrahealth.com

+ (844) 272-6337
triquetrahealth.com

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/triquetra-health-launches-mental-magnesium–first-dual-pathway-brain-formula-combining-patented-bbb-crossing-magtein-with-ata-mg-neural-excitation-control-302836854.html

SOURCE Triquetra Health LLC